(Total Views: 125)
Posted On: 11/04/2020 10:40:50 AM
Post# of 125257
$CRSP News Article - CRISPR/Cas9 Gene-Editing Therapy CTX001(TM) for Severe Hemoglobinopathies Accepted for Plenary Presentation at the 62nd American Society of Hematology (ASH) Meeting and Exposition https://marketwirenews.com/news-releases/cris...58180.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
